3T Biosciences Strengthens Leadership Team with Promotion of Marvin Gee, Ph.D., to Chief Research Officer and Appointment of Barbara Sennino, Ph.D., as Senior Vice President and Head of Early Development

SOUTH SAN FRANCISCO, Calif., March 4, 2025 /PRNewswire/ — 3T Biosciences (“3T”), an immunotherapy company changing the future of treatment for solid tumors and other immune-mediated diseases, today announced the promotion of Marvin Gee, Ph.D., to chief research officer and the…